RJA
HLTH

Raymond James & Associates’s Cue Health Inc. Common Stock HLTH Stock Holding History

Raymond James & Associates’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,958
Closed -$41.3K – 4115
2022
Q4 		$41.3K Sell
19,958
-2,680
-12% -$8.47K ﹤0.01% 3734
2022
Q3 		$68K Buy
+22,638
New +$80.2K ﹤0.01% 3672

Other funds holding HLTH

KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's HLTH Position: Q1 2023 in Review

Raymond James & Associates sold out of Cue Health Inc. Common Stock (HLTH) in Q1 2023, closing a stake of 19,958 shares — an estimated $41.3K sold.

Raymond James & Associates first reported a position in HLTH in Q3 2022 and held it in 2 quarters. The position peaked at $68K in Q3 2022. 99 funds tracked by Wall St. Rank hold HLTH as of Q1 2023.

  • Raymond James & Associates reported no remaining Cue Health Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 19,958 Cue Health Inc. Common Stock shares in Q1 2023, an estimated $41.3K.
  • Raymond James & Associates first reported a position in Cue Health Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Raymond James & Associates's Cue Health Inc. Common Stock position peaked at $68K in Q3 2022.
  • 99 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.